Sentcell (Drug Discovery) Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 1

Sentcell (Drug Discovery) General Information

Description

Developer of human rejuvenation therapies designed to reverse aging and combat diseases. The company focuses on reversing or slowing the cellular aging process, specifically targeting T cells to improve healthspan and extend human lifespan, enabling patients to increase lifespan and stay healthier.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 607 Sloane Avenue
  • London SW3 3EL
  • England, United Kingdom
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 607 Sloane Avenue
  • London SW3 3EL
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sentcell (Drug Discovery) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 01-Nov-2024 Completed Startup
To view Sentcell (Drug Discovery)’s complete valuation and funding history, request access »

Sentcell (Drug Discovery) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sentcell (Drug Discovery) Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
The TLS Incubator Accelerator/Incubator
To view Sentcell (Drug Discovery)’s complete investors history, request access »

Sentcell (Drug Discovery) FAQs

  • When was Sentcell (Drug Discovery) founded?

    Sentcell (Drug Discovery) was founded in 2019.

  • Where is Sentcell (Drug Discovery) headquartered?

    Sentcell (Drug Discovery) is headquartered in London, United Kingdom.

  • What is the size of Sentcell (Drug Discovery)?

    Sentcell (Drug Discovery) has 3 total employees.

  • What industry is Sentcell (Drug Discovery) in?

    Sentcell (Drug Discovery)’s primary industry is Drug Discovery.

  • Is Sentcell (Drug Discovery) a private or public company?

    Sentcell (Drug Discovery) is a Private company.

  • What is Sentcell (Drug Discovery)’s current revenue?

    The current revenue for Sentcell (Drug Discovery) is .

  • Who are Sentcell (Drug Discovery)’s investors?

    The TLS Incubator has invested in Sentcell (Drug Discovery).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process